Harness the power of automation to execute streamlined end-to-end safety solutions while reducing costs.
Pharmacovigilance is becoming ever more complex. With growing numbers of safety data sources and adverse event reports, there is a need to leverage new innovations to scale operations and maintain cost-effectiveness. IQVIA is leading the charge in leveraging artificial intelligence (AI) and smart machines in identifying, ingesting and reporting out safety signals in structured and unstructured data. This insight brief, authored by IQVIA experts, explains how pharmaceutical companies can leverage these innovative approaches and address the growing volumes of adverse event data without sacrificing quality or compliance.
Harness the power of automation to execute streamlined end-to-end safety solutions while reducing costs.
Meet the challenge of changing stakeholder demands and increasing cost constraints with IQVIA's integrated technology services and analytics-driven offerings.
Harness the power of global human expertise combined with automation, artificial intelligence (AI) and machine learning (ML) to design, build and execute end-to-end safety solutions.
Decrease clinical development costs and increase study quality using our global functional resources and flexible services, and get more value from your R&D spend.
Learn how unparalleled data, domain expertise, and technologies enable AI-powered solutions that are purpose-built for healthcare.